EMEA-002431-PIP01-18 - paediatric investigation plan
Alectinib
PIPHuman
Roche Registration GmbH
Tel. +41 616879411
E-mail: global.paediatrics@roche.com
P/0359/2018: EMA decision of 7 December 2018 on the granting of a product specific waiver for alectinib (Alecensa), (EMEA-002431-PIP01-18)